Loading...
AKAN logo

Akanda Corp.NasdaqCM:AKAN Stock Report

Market Cap US$10.9m
Share Price
US$20.48
My Fair Value
n/a
1Y-75.7%
7D-24.1%
Portfolio Value
View

Akanda Corp.

NasdaqCM:AKAN Stock Report

Market Cap: US$10.9m

Akanda (AKAN) Stock Overview

As of August 21, 2025, Akanda Corp. was acquired by First Towers & Fiber Corp., in a reverse merger transaction. More details

AKAN fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

AKAN Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Akanda Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Akanda
Historical stock prices
Current Share PriceUS$20.48
52 Week HighUS$209.03
52 Week LowUS$2.30
Beta14.61
1 Month Change522.49%
3 Month Change407.71%
1 Year Change-75.73%
3 Year Change-99.63%
5 Year Changen/a
Change since IPO-99.90%

Recent News & Updates

Recent updates

Seeking Alpha Sep 26

Akanda gains ahead of plans for first shipment of medical cannabis to Germany

Akanda (NASDAQ:AKAN) prepares for first export shipment from its Portugal-based Holigen operation in the coming weeks. The company’s EU GMP certified indoor grow facility in Sintra received its first purchase order and is expected to make its first export shipment to Germany imminently. The company recently entered into an agreement to deliver 1,000 kilograms of high-grade medical cannabis flower to German pharmacies through the Cansativa platform. Cansativa will have a right of first refusal to take on additional quantities that could result in the full capacity utilization of Holigen’s 2,000 kilograms per annum indoor production capacity. The deal ranks as one of the largest supply agreements in the European medical cannabis industry. The company is targeting a leading 10% market share position of German medical cannabis imports, with room for additional expansion and growth.  Shares +3.65% premarket.
Seeking Alpha Sep 08

Akanda adds Aurora Cannabis founder as Chair of advisory board

U.K.-based cannabis player Akanda Corp. (NASDAQ:AKAN) announced Thursday that Terry Booth, the founder of its Canadian rival Aurora Cannabis Inc. (ACB), has joined as Chair of the company’s newly formed Advisory Board. AKAN said that Mr. Booth, a founder of ACB, has given leadership to drive over 30 acquisitions and transactions over the past five years. “Having Terry on board as an advisor is a powerful validation of our strategy and our potential to lead the emerging cannabis market in Europe,” Chief Executive of the company Tej Virk noted. Meanwhile, Mr. Booth drew parallels between AKAN and ACB, adding: “I believe that there is significant potential in Akanda and I see similarities to it and when we were at Aurora in the stages before our explosive growth.” In 2020, Mr. Booth announced his retirement from ACB as its CEO.
Seeking Alpha Aug 24

Akanda adds new hires eyeing European expansion

U.K.-based cannabis cultivator Akanda Corp. (NASDAQ:AKAN) announced the appointment of Tom Flow as its Chief Operating Officer and Steven George as the Commercial Director as the company intends to improve its profitability in the European medical cannabis market. Mr. Flow will also serve as the Managing Director of Holigen Limited, which AKAN acquired from The Flowr Corporation in May 2022. AKAN said he has more than 15 years of direct experience in the cannabis industry, including large-scale EU GMP-certified cultivation facilities. Mr. George, formerly the Iberian Country Manager and European Alliance Manager at Tilray (TLRY), has offered independent advisory services to cannabis clients in Europe since he left the Canadian company. “Adding proven and elite global cannabis executives like Tom and Steven is an important milestone for Akanda, expanding our capabilities and growing our leadership as we scale,” noted AKAN’s Chief Executive Tej Virk.

Shareholder Returns

AKANUS PharmaceuticalsUS Market
7D-24.1%-12.9%-0.9%
1Y-75.7%34.9%24.4%

Return vs Industry: AKAN underperformed the US Pharmaceuticals industry which returned 34.9% over the past year.

Return vs Market: AKAN underperformed the US Market which returned 24.4% over the past year.

Price Volatility

Is AKAN's price volatile compared to industry and market?
AKAN volatility
AKAN Average Weekly Movement70.9%
Pharmaceuticals Industry Average Movement10.0%
Market Average Movement7.2%
10% most volatile stocks in US Market16.2%
10% least volatile stocks in US Market3.1%

Stable Share Price: AKAN's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: AKAN's weekly volatility has increased from 40% to 71% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2021n/aKatie Fieldwww.akandacorp.com

As of August 21, 2025, Akanda Corp. was acquired by First Towers & Fiber Corp., in a reverse merger transaction. Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products. The company was incorporated in 2021 and is headquartered in Toronto, Canada.

Akanda Corp. Fundamentals Summary

How do Akanda's earnings and revenue compare to its market cap?
AKAN fundamental statistics
Market capUS$10.94m
Earnings (TTM)-US$2.40m
Revenue (TTM)US$836.66k
13.1x
P/S Ratio
-4.6x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AKAN income statement (TTM)
RevenueUS$836.66k
Cost of RevenueUS$628.28k
Gross ProfitUS$208.38k
Other ExpensesUS$2.60m
Earnings-US$2.40m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-4.48
Gross Margin24.91%
Net Profit Margin-286.30%
Debt/Equity Ratio5.6%

How did AKAN perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/16 04:17
End of Day Share Price 2026/05/15 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Akanda Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.